Michelle P. Freund
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michelle P. Freund has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Aki Nikolaidis
Child Mind Institute
1 shared publication Alan E. Simon
Office of the Director, National Institutes of Health, Bethesda, MD, 20892, USA
1 shared publication- Andrew A. Bremer
Office of Nutrition Research, National Institutes of Health, Bethesda MD, USA
1 shared publication Chloe J. Jordan
National Institute on Drug Abuse, National Institutes of Health, Bethesda, USA
1 shared publicationJoshua A. Gordon
National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland
1 shared publicationKatia D. Howlett
National Institute on Drug Abuse, National Institutes of Health, Bethesda, USA
1 shared publication
Latest Publications
- Open Access
- 14 April 2026
- Published by Elsevier in JAACAP Open
- Vol. 4 (4) , 701-712
Negative Online Experiences and Reporting Rates in Youth With Mental Health Conditions
- 14 April 2026
- Published by Elsevier in JAACAP Open
- Vol. 4 (4) , 701-712
Open AccessNegative Online Experiences and Reporting Rates in Youth With Mental Health Conditions
- Open Access
- 1 May 2021
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 78 (5) , 471-472
The Healthy Brain and Child Development Study—Shedding Light on Opioid Exposure, COVID-19, and Health Disparities
This Viewpoint describes the planned Healthy Brain and Child Development Study, which will investigate the associations of parental substance abuse, coronavirus
- 1 May 2021
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 78 (5) , 471-472
Open AccessThe Healthy Brain and Child Development Study—Shedding Light on Opioid Exposure, COVID-19, and Health Disparities
This Viewpoint describes the planned Healthy Brain and Child Development Study, which will investigate the associations of parental substance abuse, coronavirus
- Open Access
- 25 January 2021
- Published by Springer Nature in Journal of Perinatology
- Vol. 41 (6) , 1213-1215
Toward the use of buprenorphine in infants for neonatal opioid withdrawal syndrome: summary of an NIH workshop
- 25 January 2021
- Published by Springer Nature in Journal of Perinatology
- Vol. 41 (6) , 1213-1215
Open AccessToward the use of buprenorphine in infants for neonatal opioid withdrawal syndrome: summary of an NIH workshop
- Open Access
- 22 October 2020
- Published by Springer Nature in Adversity and Resilience Science
- Vol. 1 (4) , 217-221
Introduction to the Special Issue on “Informing Longitudinal Studies on the Effects of Maternal Stress and Substance Use on Child Development: Planning for the HEALthy Brain and Child Development (HBCD) Study”
The HEALthy Brain and Child Development (HBCD) study will establish a large cohort of pregnant women from regions of the country significantly affected by the opioid crisis and follow them and their children for at least 10 years. Findings from this cohort will help researchers understand normative childhood brain development as well as the long-term impact of prenatal and postnatal opioid and other drug and environmental exposures. The study will collect data on pregnancy and fetal development; infant and early childhood structural and functional brain imaging; anthropometrics; medical history; family history; biospecimens; and social, emotional, and cognitive development. Knowledge gained from this research will be critical to help predict and prevent some of the known effects of prenatal and postnatal exposure to certain drugs or environmental exposures, including risk for future substance use, mental disorders, and other behavioral and developmental problems. In this special issue, a subset of investigators that received funding for planning grants for the HBCD study provide careful guidelines and frameworks for study design, recruitment and retention of vulnerable populations, culturally sensitive practices, and biospecimen and neurodevelopmental assessment recommendations gathered in feasibility studies that will help inform the full HBCD study planned to begin recruitment in 2022.
- 22 October 2020
- Published by Springer Nature in Adversity and Resilience Science
- Vol. 1 (4) , 217-221
Open AccessIntroduction to the Special Issue on “Informing Longitudinal Studies on the Effects of Maternal Stress and Substance Use on Child Development: Planning for the HEALthy Brain and Child Development (HBCD) Study”
The HEALthy Brain and Child Development (HBCD) study will establish a large cohort of pregnant women from regions of the country significantly affected by the opioid crisis and follow them and their children for at least 10 years. Findings from this cohort will help researchers understand normative childhood brain development as well as the long-term impact of prenatal and postnatal opioid and other drug and environmental exposures. The study will collect data on pregnancy and fetal development; infant and early childhood structural and functional brain imaging; anthropometrics; medical history; family history; biospecimens; and social, emotional, and cognitive development. Knowledge gained from this research will be critical to help predict and prevent some of the known effects of prenatal and postnatal exposure to certain drugs or environmental exposures, including risk for future substance use, mental disorders, and other behavioral and developmental problems. In this special issue, a subset of investigators that received funding for planning grants for the HBCD study provide careful guidelines and frameworks for study design, recruitment and retention of vulnerable populations, culturally sensitive practices, and biospecimen and neurodevelopmental assessment recommendations gathered in feasibility studies that will help inform the full HBCD study planned to begin recruitment in 2022.